Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | GALR3 | O60755 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL372207 | 0.95 | TSHR (0.70) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| Hexane SCHEMBL15841420 | 0.93 | TSHR (0.67) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| Octane SCHEMBL10883673 | 0.93 | TSHR (0.67) | TSHRLMNAALDH1A1PRKCAMAPT | |
| Heptane SCHEMBL2123028 | 0.93 | TSHR (0.67) | TSHRLMNAALDH1A1PRKCAMAPT | |
| Heptane SCHEMBL350561 | 0.93 | TSHR (0.67) | TSHRLMNAALDH1A1PRKCAMAPT | |
| Butyl Alcohol SCHEMBL15004902 | 0.89 | TSHR (0.61) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| Propane SCHEMBL27531646 | 0.87 | TSHR (0.82) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| Butyl Chloride SCHEMBL10820809 | 0.87 | TSHR (0.58) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| Butyl Alcohol SCHEMBL28312338 | 0.87 | TSHR (0.58) | TSHRLMNAALDH1A1CHRM2CHRM4 | |
| 1-Pentanol SCHEMBL11376862 | 0.87 | TSHR (0.58) | TSHRLMNAALDH1A1PRKCAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11958845-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-114846012-B | 2-isoindole-1, 3, 4-oxadiazole derivatives useful as HDAC6 inhibitors | 武田药品工业株式会社 | 2024-01-26 | — | — | CN | disclosed |
| US-20230183227-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-06-15 | — | — | US | disclosed |
| EP-4034536-A1 | 2-ISOINDOL-1,3,4-OXADIAZOLE DERIVATIVES USEFUL AS HDAC6 INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2022-08-03 | — | — | EP | disclosed |
| CN-114846012-A | 2-isoindole-1, 3, 4-oxadiazole derivatives useful as HDAC6 inhibitors | 武田药品工业株式会社 | 2022-08-02 | — | — | CN | disclosed |
| EP-3820696-A1 | POLY(VINYL ACETAL) RESIN COMPOSITIONS, LAYERS, AND INTERLAYERS HAVING ENHANCED PROPERTIES | Solutia Inc. (US) | 2021-05-19 | — | — | EP | disclosed |
| WO-2021060567-A1 | 2-ISOINDOL-1,3,4-OXADIAZOLE DERIVATIVES USEFUL AS HDAC6 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-04-01 | — | — | WO | disclosed |
| US-20210094944-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-04-01 | — | — | US | disclosed |
| CN-112334309-A | Poly (vinyl acetal) resin compositions, layers and interlayers having enhanced properties | 首诺公司 | 2021-02-05 | — | — | CN | disclosed |
| US-10717862-B2 | Poly(vinyl acetal) resin compositions, layers, and interlayers having enhanced properties | SOLUTIA INC. (US) | 2020-07-21 | — | — | US | disclosed |
| CN-101341113-B | Process for preparing octenoic acid derivatives | REUTER CHEMISCHE APPBAU KG | 2013-07-10 | — | — | CN | disclosed |
| US-8450519-B2 | Process for preparing octenoic acid derivatives | REUTER CHEMISCHER APPARATEBAU KG (DE) | 2013-05-28 | — | — | US | disclosed |
| US-8445708-B2 | Process for preparing chiral octenoic acid derivatives | REUTER CHEMISCHER APPARATEBAU KG (DE) | 2013-05-21 | — | — | US | disclosed |
| US-20120178959-A1 | PROCESS FOR PREPARING OCTENOIC ACID DERIVATIVES | REUTER CHEMISCHER APPARATEBAU KG | 2012-07-12 | — | — | US | disclosed |
| US-20090221848-A1 | PROCESS FOR PREPARING OCTENOIC ACID DERIVATIVES | REUTER CHEMISCHER APPARATEBAU KG (DE) | 2009-09-03 | — | — | US | disclosed |
| CN-101341113-A | Process for preparing octenoic acid derivatives | REUTER CHEMISCHE APPBAU KG (DE) | 2009-01-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221848-A1 | PROCESS FOR PREPARING OCTENOIC ACID DERIVATIVES | ALOX5, ALOX12, ALOX15 | TSHR 4093/4885LMNA 560/4885ALDH1A1 581/4885 |
| US-20120178959-A1 | PROCESS FOR PREPARING OCTENOIC ACID DERIVATIVES | ALOX5, ALOX12, ALOX15 | TSHR 4093/4885LMNA 560/4885ALDH1A1 581/4885 |
| US-11958845-B2 | Heterocyclic compound | HDAC6, HDAC1, HDAC5 | TSHR 3746/4885LMNA 3611/4885ALDH1A1 382/4885 |
| US-20210094944-A1 | HETEROCYCLIC COMPOUND | HDAC6, HDAC1, HDAC5 | TSHR 3746/4885LMNA 3611/4885ALDH1A1 382/4885 |
| US-20230183227-A1 | HETEROCYCLIC COMPOUND | HDAC6, HDAC1, HDAC5 | TSHR 3671/4885LMNA 3608/4885ALDH1A1 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.